Peter Valent

ORCID: 0000-0003-0456-5095
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Mast cells and histamine
  • Acute Myeloid Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Eosinophilic Disorders and Syndromes
  • Food Allergy and Anaphylaxis Research
  • Asthma and respiratory diseases
  • Chronic Lymphocytic Leukemia Research
  • Allergic Rhinitis and Sensitization
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Urticaria and Related Conditions
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Polyamine Metabolism and Applications
  • Monoclonal and Polyclonal Antibodies Research
  • Protein Degradation and Inhibitors
  • Click Chemistry and Applications
  • melanin and skin pigmentation
  • Drug-Induced Adverse Reactions
  • Acute Lymphoblastic Leukemia research
  • Multiple Myeloma Research and Treatments
  • Hematopoietic Stem Cell Transplantation
  • Contact Dermatitis and Allergies
  • Autoimmune Bullous Skin Diseases
  • Hematological disorders and diagnostics
  • Lymphoma Diagnosis and Treatment
  • Histone Deacetylase Inhibitors Research

Medical University of Vienna
2016-2025

Ludwig Boltzmann Institute for Digital Health and Prevention
2019-2025

Vienna General Hospital
2007-2024

Hanusch Hospital
2008-2024

Comprehensive Cancer Center Vienna
2012-2024

University of Vienna
2006-2023

TU Wien
2020-2023

Massachusetts General Hospital
2023

University of Oxford
2023

Slovak University of Technology in Bratislava
2020-2022

Purpose The karyotype is a strong independent prognostic factor in myelodysplastic syndromes (MDS). Since the implementation of International Prognostic Scoring System (IPSS) 1997, knowledge concerning impact abnormalities has increased substantially. present study proposes new and comprehensive cytogenetic scoring system based on an international data collection 2,902 patients. Patients Methods were included from German-Austrian MDS Study Group (n = 1,193), Risk Analysis Workshop 816),...

10.1200/jco.2011.35.6394 article EN Journal of Clinical Oncology 2012-02-14

A complementary DNA encoding a pollen allergen from white birch ( Betula verrucosa ) that was isolated library with serum immunoglobulin E pollen-allergic individual revealed significant sequence homology to profilins. The recombinant protein showed high affinity poly-L-proline. Immunoglobulin antibodies allergic individuals bound natural and profilin also human profilin. In addition, induced histamine release blood basophils of profilin-allergic individuals, but not sensitized other plant...

10.1126/science.1857985 article EN Science 1991-08-02

Type I allergy is a major health problem in industrialized countries where up to 15% of the population suffer from allergic symptoms (rhinitis, conjunctivitis, and asthma). Previously, we identified cDNA clone that encoded birch pollen allergen as profilin. Profilins constitute ubiquitous family proteins control actin polymerization eukaryotic cells; particular, profilin participates acrosomal reaction animal sperm cells. Although profilins had been unknown plants so far, our finding led...

10.1084/jem.175.2.377 article EN The Journal of Experimental Medicine 1992-02-01

Activation of tissue mast cells (MCs) and their abnormal growth accumulation in various organs are typically found primary MC disorders also referred to as mastocytosis. However, increasing numbers patients now being informed that clinical findings due activation (MCA) is neither associated with mastocytosis nor a defined allergic or inflammatory reaction. In other MCA, MCs appear be clonal cells, but criteria for diagnosing not met. A working conference was organized 2010 the aim define MCA...

10.1159/000328760 article EN International Archives of Allergy and Immunology 2011-10-27

BACKGROUND: Risk stratification and therapeutic decision-making for myelodysplastic syndromes (MDS) are based on the International Prognostic Scoring System–Revised (IPSS-R), which considers hematologic parameters cytogenetic abnormalities. Somatic gene mutations not yet used in risk of patients with MDS. METHODS: To develop a clinical-molecular prognostic model (IPSS-Molecular [IPSS-M]), pretreatment diagnostic or peridiagnostic samples from 2957 MDS were profiled 152 genes. Clinical...

10.1056/evidoa2200008 article EN NEJM Evidence 2022-06-12

10.1038/s41591-020-1008-z article EN Nature Medicine 2020-08-03

Advanced systemic mastocytosis comprises rare hematologic neoplasms that are associated with a poor prognosis and lack effective treatment options. The multikinase inhibitor midostaurin inhibits KIT D816V, primary driver of disease pathogenesis. We conducted an open-label study oral at dose 100 mg twice daily in 116 patients, whom 89 mastocytosis-related organ damage were eligible for inclusion the efficacy population; 16 had aggressive mastocytosis, 57 neoplasm, mast-cell leukemia. outcome...

10.1056/nejmoa1513098 article EN New England Journal of Medicine 2016-06-29

The discipline of Cardio-Oncology has seen tremendous growth over the past decade. It is devoted to cardiovascular (CV) care cancer patient, especially mitigation and management CV complications or toxicities therapies, which can have profound implications on prognosis. To that effect, many studies assessed in patients undergoing various types therapies; however, direct comparisons proven difficult due lack uniformity toxicity endpoints. Similarly, clinical practice, there be substantial...

10.1093/eurheartj/ehab674 article EN European Heart Journal 2021-09-10

The history of phenothiazines, from methylene blue via chlorpromazine to recently synthesized isomeric derivatives various neuroleptics, is reviewed in the light their antimicrobial activity and Paul Ehrlich's receptor concept. latter clearly line with most modern theories concerning drug action stereo-isomeric compounds.

10.1159/000443526 article EN Journal of Innate Immunity 2016-01-01

Objective — A number of studies have shown that statins decrease morbidity and mortality in patients with cardiovascular diseases. The anti-inflammatory effects recently been implicated the clinical benefit can be obtained treatment atherosclerosis. Little is known about mechanisms by which counteract inflammation. Methods Results In this study, we asked whether simvastatin influence vitro vivo production proinflammatory cytokines interleukin (IL)-6, IL-8, monocyte chemoattractant protein-1....

10.1161/01.atv.0000022694.16328.cc article EN Arteriosclerosis Thrombosis and Vascular Biology 2002-07-01

IgE-mediated allergy affects >25% of the population in industrialized countries. Repeated contact with disease-eliciting allergens induces rises allergen-specific IgE Abs and progression disease to more severe manifestations. Our study uses a type vaccine that is based on genetically modified allergen derivatives treat allergic patients. We developed hypoallergenic major birch pollen allergen, Bet v 1, by genetic engineering vaccinated pollen-allergic patients (n = 124) double-blind,...

10.1073/pnas.0404735101 article EN Proceedings of the National Academy of Sciences 2004-08-14
Coming Soon ...